Business Performance Forecast
Consolidated Results Forecasts
（Billions of yen）
| FY2024（results） | FY2025 (previous forecast) as of Aug. 7, 2025 | FY2025 (revised forecast) as of Nov. 10, 2025 | |
|---|---|---|---|
| Net sales | 773.5 | 750.0 | 730.0 |
| Operating profit | 50.8 | 46.0 | 44.0 |
| Ordinary profit | 60.3 | 50.0 | 50.0 |
| Profit attributable to owners of parent |
45.5 | 36.0 | (17.0) |
Main reasons for revising the forecasts as described above include a projection that full-year earnings will fall short of the previous forecasts due to the recording of impairment losses during the second quarter of the fiscal year ending March 31, 2026.
The details of the impairment loss are as below.
As announced on September 17, 2025, MGC Specialty Chemicals Netherlands B.V. (MSCN), a Netherlands-based consolidated subsidiary of MGC, has temporarily suspended the construction of its meta-xylenediamine (MXDA) manufacturing facility due to the deterioration of the business environment.
Given this, MGC has examined the recoverable value of noncurrent assets possessed by MSCN. As a result, MGC decided to record impairment losses totaling ¥50.2 billion for the second quarter of the fiscal year ending March 31, 2026.
Forecast by Segment
（Billions of yen）
| FY2024（results） | FY2025 (previous forecast) as of Aug. 7, 2025 | FY2025 (revised forecast) as of Nov. 10, 2025 | |
|---|---|---|---|
| Net sales | 773.5 | 750.0 | 730.0 |
| Green Energy & Chemicals | 323.1 | 301.3 | 288.0 |
| Specialty Chemicals | 444.1 | 445.9 | 439.3 |
| Other and Adjustment | 6.2 | 2.6 | 2.5 |
| Operating profit | 50.8 | 46.0 | 44.0 |
| Green Energy & Chemicals | 12.7 | 10.2 | 8.1 |
| Specialty Chemicals | 41.3 | 41.0 | 40.5 |
| Other and Adjustment | (3.2) | (5.2) | (4.6) |
| Ordinary profit | 60.3 | 50.0 | 50.0 |
| Green Energy & Chemicals | 20.5 | 14.8 | 10.4 |
| Specialty Chemicals | 43.9 | 40.1 | 42.7 |
| Other and Adjustment | (4.1) | (4.9) | (3.1) |